Updates

BIG PHARMA EARNINGS WATCH: AMGEN AND PFIZER

Aug 6, 2025

Amgen and Pfizer Bring in Billions of Revenue in Q2 Following Continued Price Read More

DOSE OF REALITY: REPORT FINDS BIG PHARMA RIDER IN TAX LAW LIKELY TO COST SENIORS AND TAXPAYERS FAR MORE THAN PREVIOUSLY ESTIMATED

Aug 5, 2025

The Wall Street Journal Finds Pharma-Backed Provision Likely to Enable Big Read More

BIG PHARMA EARNINGS WATCH: ABBVIE AND BRISTOL MYERS SQUIBB

Aug 4, 2025

AbbVie and Bristol Myers Squibb Report Better-Than-Expected Earnings in the Read More

BIG PHARMA EARNINGS WATCH: ASTRAZENECA AND GSK

Jul 31, 2025

Pair of Big Pharma Giants Beat Expectations After Hiking Prices on Nearly 50 Read More

Second Opinion: Big Pharma’s Advertising Carries a Big Price Tag for American Patients and Taxpayers

Jul 29, 2025

Washington Post Editorial Misses Connection Between DTC Advertising and Higher Read More

BIG PHARMA EARNINGS WATCH: ROCHE

Jul 29, 2025

Roche Continues Hiking Prices on Blockbuster Drugs While Beating Wall Street Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Jul 22, 2025

Pharmaceutical Giant Beats Wall Street Expectations While Hiking Prices on Read More

CSRxP STATEMENT ON U.S. SENATE REINTRODUCTION OF THE ETHIC ACT

Jul 16, 2025

Coalition Commends Bipartisan Group of Lawmakers for Commitment to Cracking Read More

CSRxP STATEMENT ON BIG PHARMA GIVEAWAY IN RECONCILIATION BILL TEXT

Jun 28, 2025

Pharma-Backed Policy Would Cost Seniors and Taxpayers Billions of Dollars in Read More